Resources for you and your patients

Practicalities

SC Checklist beginning of treatment

Includes a first use checklist of Darzalex® SC.

Darzalex® SC Practical Guide

Includes DARZALEX® SC handling and administration info, pre and post-injection medications, and more

Study profiles

CASSIOPEIA study

Summary of study design, efficacy results and safety profile for DVTd in transplant-eligible NDMM.

MAIA study

Summary of study design, efficacy results and safety profile for DRd in transplant-ineligible NDMM.

ALCYONE study

Summary of study design, efficacy results and safety profile for DVMP in transplant-ineligible NDMM.

Dosing schedules

Dosing schedules for all Darzalex® treatment regimens

Patient support materials

Resources to support your patients

My Care is a project that aims to support healthcare professionals and patients throughout their journey.

JMC: Janssen Medical Cloud

MRD: minimal residue disease

PFS: progression-free disease

QOL: quality of life

Titular da Autorização de Introdução no Mercado: Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Bélgica.
Para mais informações deverá contactar o Representante do Titular da Autorização de Introdução no Mercado: Janssen-Cilag Farmacêutica, Lda.

Medicamento de receita médica restrita, de utilização reservada a certos meios especializados.

Antes de prescrever consulte o RCM completo.

RCM de Darzalex®, veja aqui